Ashton Thomas Private Wealth’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Buy
16,502
+11
+0.1% +$239 0.01% 806
2026
Q1
$286K Buy
+16,491
New +$312K 0.01% 900

Other funds holding CDNA

Ashton Thomas Private Wealth's CDNA Position: Q2 2026 in Review

Ashton Thomas Private Wealth increased its CareDx (CDNA) stake by 0.07% in Q2 2026, buying an estimated $239 and bringing the position to 16,502 shares worth $470K. The position accounts for 0.01% of the portfolio, ranked #806.

Ashton Thomas Private Wealth first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Ashton Thomas Private Wealth held 16,502 shares of CareDx worth $470K as of Q2 2026.
  • Ashton Thomas Private Wealth bought 11 CareDx shares in Q2 2026, an estimated $239.
  • CareDx made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #806 holding.
  • Ashton Thomas Private Wealth first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.